REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144 | -54.7% | 12,583 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $318 | -13.6% | 12,583 | +10.3% | 0.00% | 0.0% |
| Q1 2023 | $368 | +49.6% | 11,412 | -14.5% | 0.00% | +50.0% |
| Q4 2022 | $246 | -99.9% | 13,346 | +15.0% | 0.00% | -33.3% |
| Q3 2022 | $313,000 | +104.6% | 11,607 | +5.0% | 0.00% | +200.0% |
| Q2 2022 | $153,000 | -31.4% | 11,052 | -3.3% | 0.00% | -50.0% |
| Q1 2022 | $223,000 | -44.8% | 11,428 | -53.7% | 0.00% | +100.0% |
| Q4 2021 | $404,000 | +15.8% | 24,708 | +97.1% | 0.00% | -66.7% |
| Q3 2021 | $349,000 | -11.2% | 12,536 | -5.4% | 0.00% | 0.0% |
| Q2 2021 | $393,000 | +73.1% | 13,255 | +63.2% | 0.00% | -66.7% |
| Q1 2021 | $227,000 | -9.2% | 8,120 | -7.9% | 0.01% | 0.0% |
| Q4 2020 | $250,000 | +13.1% | 8,815 | +0.4% | 0.01% | -10.0% |
| Q3 2020 | $221,000 | – | 8,776 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |